Search - tctmd.com

Displaying 201 - 220 of 393

Sort: Relevancy | Date

News Daily News

Ischemic Heart Disease the Leading Cause of Death Globally

Michael O'Riordan

September 19, 2017

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

News Daily News

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Michael O'Riordan

September 15, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

September 07, 2017

News Conference News ESC 2017

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

Todd Neale

September 05, 2017

News Conference News ESC 2017

Inclisiran Offers Sustained LDL-Lowering Through 1 Year: ORION-1

Michael O'Riordan

September 05, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Conference News ESC 2017

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

Michael O'Riordan

August 30, 2017

News Conference News ESC 2017

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Michael O'Riordan

August 29, 2017

News Conference News ESC 2017

Less Is More? Health Benefits of Fruits, Vegetables, and Legumes Seen at Lower Intake Levels

Michael O'Riordan

August 29, 2017

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

Todd Neale

August 28, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Michael O'Riordan

August 26, 2017

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

Advertisement

Ischemic Heart Disease the Leading Cause of Death Globally

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

Inclisiran Offers Sustained LDL-Lowering Through 1 Year: ORION-1

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Less Is More? Health Benefits of Fruits, Vegetables, and Legumes Seen at Lower Intake Levels

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

ESC Updates Guidelines for Treating STEMI Patients

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Evolocumab Not Cost-Effective at Current List Price

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content